Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naftopidil in Male Patients With LUTS Associated With BPH
NCT01922375Phase 4Completed
- Sponsor
- Dong-A Pharmaceutical
- Start
- Dec 2011
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naftopidil in benign prostatic hyperplasia (BPH), sponsored by Dong-A Pharmaceutical. Started Dec 2011; status: completed.
02
Drugs
naftopidil
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT01922375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01922375.